Key result
Early GLS and troponin surveillance enables prompt cardioprotection to prevent anthracycline-induced cardiomyopathy.
Why the study?
Anthracyclines may cause severe left ventricle systolic dysfunction with poor prognosis, necessitating understanding of mechanisms, risk factors, and prevention strategies.
Answers are grounded in this paper and cite their sources.
Anticancer antibiotics, anthracyclines, may cause severe left ventricle systolic dysfunction that is associated with poor clinical prognosis. In this review, we discuss the mechanisms and risk factors of anthracycline-induced cardiotoxicity and cardiomyopathy, among which the cumulative administered dose of anthracyclines and concurrent cardiovascular diseases are the most important. We also present strategies for primary and secondary prevention of anthracycline-induced cardiotoxicity via rigorous assessment of early signs of left ventricular dysfunction.
No takes yet. Share an insight, caveat, or question.
Chazova et al. (2015) conducted a review in Anthracycline-induced cardiomyopathy. Cardioprotective treatment and cardiologic monitoring was evaluated. Early detection of subclinical left ventricular dysfunction via global longitudinal strain and troponin I enables prompt cardioprotective intervention to prevent anthracycline-induced cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: